The Therapeutic Effect of Expressive Writing.
The goal of this clinical trial is to understand the impact of compassionate expressive writing in people living with and beyond cancer. The main question it aims to answer is: Does compassionate expressive writing have any impact on well-being outcomes in people living with and beyond cancer, such as body compassion,
| Condition(s) | Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to understand the impact of compassionate expressive writing in people living with and beyond cancer. The main question it aims to answer is: Does compassionate expressive writing have any impact on well-being outcomes in people living with and beyond cancer, such as body compassion, self-compassion, quality of life and psychological well-being outcomes ? Researchers will compare compassionate expressive writing with a standard expressive writing task (with no compassionate prompt) to see if there is a difference in self-reported body compassion, self-compassion, quality of life and psychological well-being outcomes between the two conditions. Participants will : Complete a series of pre-intervention questionnaires. Be assigned to one of the two writing c |
| Who can participate | Inclusion Criteria: * To have experienced an internal or external change to their body due to any form of cancer and/or its treatment at any point in their lives. * To be 18 or older. * The ability to read and write in English. * To have the ability to provide informed consent. Exclusion Criteria: * Distress levels that make participation safe or inappropriate due to cancer prognosis or a mental health condition. (This is flagged by the score on the IES questionnaire.) * Inability to realistically commit to a 4-week intervention due to poor physical or mental health or other personal commitments. * Inability to provide informed consent. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Royal Cornwall Hospitals Trust |
| Locations | Truro, Cornwall, United Kingdom |
| Start date | 2025-12-22 |
| NCT ID | NCT07567157 |
| Official listing | https://clinicaltrials.gov/study/NCT07567157 |